BenevolentAI société anonyme Investor Relations Material
Latest events
H1 2024
BenevolentAI société anonyme
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from BenevolentAI société anonyme
Access all reports
BenevolentAI société anonyme is active in the pharmaceutical industry, specializing in AI-enabled drug discovery. The company's core mission revolves around integrating artificial intelligence (AI) with advanced scientific research to innovate and develop new medications for complex diseases. It leverages its proprietary Benevolent Platform, an AI-driven drug discovery engine that utilizes a vast biomedical data landscape to offer a comprehensive representation of human biology across various diseases. This platform aids both in-house scientists and biopharmaceutical partners in accelerating scientific breakthroughs by harnessing the full potential of data and AI for the next generation of medical advancements. The company is headquartered in Luxembourg and its shares are listed on the Euronext Amsterdam stock exchange.
Key slides for BenevolentAI société anonyme
H1 2024
BenevolentAI société anonyme
H1 2024
BenevolentAI société anonyme
Latest articles
Texas Instruments: From Calculators to Master Capital Allocators
Texas Instruments has undergone many transformations from its origins in oil exploration to become one of the world's largest semiconductor producers.
11 Oct 2024
The Art of Portfolio Management: Lessons from Tom O'Hara
Tom O'Hara shares insights on stock picking, navigating market distractions, and the importance of one-on-one meetings with management teams.
4 Oct 2024
The Samsung Co-CEOs: Jong-Hee Han & Young-Hyun Jun
Samsung Electronics' dual-CEO structure, led by Jong-Hee Han and Young-Hyun Jun, is designed to navigate the complexities of its diverse business.
3 Oct 2024
Ticker symbol
BAI
Country
🇳🇱 Netherlands